معرفی
Dr. Sherry Wang is a tenure-track Assistant Professor at Chapman University School of Pharmacy, leading the Research Center for Healthcare AI Initiative. Her interdisciplinary research combines machine learning, epidemiology, clinical pharmacy, health economics, and health services research to improve healthcare delivery and outcomes.
- Education:
- China Pharmaceutical University – Bachelor of Science
- University of Hong Kong – Master of Philosophy
- The Chinese University of Hong Kong – Ph.D.
Her work focuses on optimizing care pathways for chronic diseases and addiction, leveraging real-world data (RWD) to address healthcare access and quality issues, particularly for populations with substance use disorders. She has international experience across Asia, Australia, and the US.
Recent scholarly trends show her work spans machine learning (e.g., opioid risk scoring bias), addiction treatment (buprenorphine utilization), and chronic disease management (metabolic syndrome, breast cancer pain). She integrates geospatial analysis and health policy evaluation into her research.
Scientific Awards:
- Recipient of AACP New Investigator Award (2022)
- Finalist, Women in AI Awards North America – AI Researcher of the Year (2025)
- CHPAMS and AFLSP Fellowships
Dr. Wang mentors graduate students, visiting scholars, undergraduates, and high school students, with one Ph.D. student receiving the James L. Doti Outstanding Graduate Student Award. Her research is funded by NIH’s AIM-AHEAD program, McGovern Foundation, Chapman University, AACP, and CRE2 at Washington University.
